11.08.2016 • News • Biotechnology • R&D

Philippe Saudan Chief Development Officer at Kuros

Kuros Biosciences has appointed Dr. Philippe Saudan as chief development officer and member of the executive board with immediate effect. With a PhD in biology
from the University of Lausanne, Switzerland, and a 16 year-career in the pharmaceutical industry, Saudan has held management roles in R&D and last served as Chief Scientific Officer of Cytos Biotechnology. Since February 2016, he has been working as Head of Integration at Kuros.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Top-Feature